CJC-1295 Ipamorelin blend peptide is a pre-combined formulation containing CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin in a single lyophilized vial. This blend is designed for researchers studying the combined activity of a GHRH analog and a GHS-R agonist in in-vitro experimental systems, eliminating the need for separate reconstitution and mixing protocols.

CJC + Ipamorelin
GHRH and GHS peptide combination for synergistic GH studies
| Weight | 0.04 lbs |
|---|---|
| Dimensions | 0.75 × 0.75 × 1.75 in |
| SIZE | 5mg/5mg, 10mg/10mg |






